Effect of andecaliximab (anti-MMP9) on proteolysis of IL-7 in vitro, TCR diversity in mice, and serum IL-7 in gastric cancer patients in combination with chemotherapy.-MedSci.cn

Effect of andecaliximab (anti-MMP9) on proteolysis of IL-7 in vitro, TCR diversity in mice, and serum IL-7 in gastric cancer patients in combination with chemotherapy.

Greenstein, AE; Zavodovskaya, M; Velasquez, M; Weissburg, P; Juric, V; Mikels-Vigdal, A; Brachmann, C

JOURNAL OF CLINICAL ONCOLOGY, 2018; 36 (5):

科室
- - 订阅+
  - 更多科室
工具
服务